DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Petrelli F. et al.
FOLFIRI-bevacizumab as first-line chemotherapy in 3500 patients with advanced colorectal cancer: a pooled analysis of 29 published trials.
Clin Colorectal Cancer 2013;
12: 145-151
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.